Royal Bank of Canada
ORGO icon

Royal Bank of Canada’s Organogenesis Holdings ORGO Stock Holding History

Royal Bank of Canada’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6K Buy
2,335
+2,287
+4,765% +$5.59K ﹤0.01% 6900
2026
Q1 		$0 Sell
48
-2,798
-98% -$9.69K ﹤0.01% 7523
2025
Q4 		$15K Buy
2,846
+1,555
+120% +$7.53K ﹤0.01% 6203
2025
Q3 		$6K Sell
1,291
-65,199
-98% -$303K ﹤0.01% 6658
2025
Q2 		$243K Buy
66,490
+11,651
+21% +$43.4K ﹤0.01% 5008
2025
Q1 		$237K Sell
54,839
-4,729
-8% -$19.1K ﹤0.01% 4574
2024
Q4 		$191K Sell
59,568
-15,210
-20% -$51K ﹤0.01% 4855
2024
Q3 		$214K Sell
74,778
-20,212
-21% -$56.7K ﹤0.01% 4766
2024
Q2 		$266K Buy
94,990
+22,716
+31% +$61K ﹤0.01% 4531
2024
Q1 		$205K Sell
72,274
-22,690
-24% -$77.1K ﹤0.01% 4668
2023
Q4 		$388K Buy
94,964
+12,821
+16% +$35.9K ﹤0.01% 4488
2023
Q3 		$261K Buy
82,143
+16,163
+24% +$51.4K ﹤0.01% 4563
2023
Q2 		$219K Buy
65,980
+7,859
+14% +$23.2K ﹤0.01% 4663
2023
Q1 		$124K Buy
58,121
+47,048
+425% +$116K ﹤0.01% 5007
2022
Q4 		$30K Buy
11,073
+10,045
+977% +$29.3K ﹤0.01% 6138
2022
Q3 		$3K Buy
1,028
+512
+99% +$2.31K ﹤0.01% 6910
2022
Q2 		$2K Sell
516
-3,873
-88% -$23.8K ﹤0.01% 6980
2022
Q1 		$34K Sell
4,389
-2,893
-40% -$22.4K ﹤0.01% 6320
2021
Q4 		$67K Buy
7,282
+1,604
+28% +$17K ﹤0.01% 6203
2021
Q3 		$80K Buy
5,678
+1,499
+36% +$23.3K ﹤0.01% 5860
2021
Q2 		$69K Buy
4,179
+861
+26% +$16K ﹤0.01% 5822
2021
Q1 		$61K Buy
3,318
+374
+13% +$5.07K ﹤0.01% 5772
2020
Q4 		$23K Buy
2,944
+2,844
+2,844% +$13.5K ﹤0.01% 6000
2020
Q3 		$0 Sell
100
-37
-27% -$146 ﹤0.01% 6838
2020
Q2 		$1K Sell
137
-1,372
-91% -$4.95K ﹤0.01% 6465
2020
Q1 		$5K Buy
1,509
+1,170
+345% +$5.01K ﹤0.01% 6046
2019
Q4 		$1K Buy
339
+239
+239% +$1.51K ﹤0.01% 6675
2019
Q3 		$1K Hold
100
– – ﹤0.01% 6492
2019
Q2 		$1K Hold
100
– – ﹤0.01% 6730
2019
Q1 		$1K Buy
+100
New +$2K ﹤0.01% 6672

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Royal Bank of Canada's ORGO Position: Q2 2026 in Review

Royal Bank of Canada increased its Organogenesis Holdings (ORGO) stake by 4,765% in Q2 2026, buying an estimated $5.59K and bringing the position to 2,335 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #6900.

Royal Bank of Canada first reported a position in ORGO in Q1 2019 and has held it in 30 quarters since. The position peaked at $388K in Q4 2023. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Royal Bank of Canada held 2,335 shares of Organogenesis Holdings worth $6K as of Q2 2026.
  • Royal Bank of Canada bought 2,287 Organogenesis Holdings shares in Q2 2026, an estimated $5.59K.
  • Organogenesis Holdings made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #6900 holding.
  • Royal Bank of Canada first reported a position in Organogenesis Holdings in Q1 2019 and has held it in 30 quarters since.
  • Royal Bank of Canada's Organogenesis Holdings position peaked at $388K in Q4 2023.
  • 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.